Latest News about NVTA
Recent news which mentions NVTA
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying
September 20, 2021
From Motley Fool
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
September 09, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
From Benzinga
Invitae Strengthens Health Data Platform With Ciitizen Acquisition
September 07, 2021
Tickers
NVTA
From Benzinga
Cathie Wood Stocks: What Names Is ARK Invest CEO Buying Now?
August 17, 2021
From InvestorPlace
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
From Benzinga
From Benzinga
20 Stocks Moving in Monday's Pre-Market Session
August 09, 2021
From Benzinga
From InvestorPlace
88 Biggest Movers From Yesterday
August 05, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021
August 04, 2021
From Benzinga
Invitae Stock Jumps As Higher Test Volume More Than Doubles Q2 Topline, Raises FY21 Sales Outlook
August 04, 2021
Tickers
NVTA
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
30 Stocks Moving in Wednesday's Pre-Market Session
August 04, 2021
From Benzinga
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
August 04, 2021
From Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 03, 2021
From Benzinga
14 Stocks Moving In Tuesday's After-Hours Session
August 03, 2021
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
Earnings Scheduled For August 3, 2021
August 03, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
July 20, 2021
From Benzinga
From Motley Fool
3 Things About Invitae That Smart Investors Should Know
July 13, 2021
From Motley Fool
Where Will ARK Genomic Revolution ETF Be in 5 Years?
July 10, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.